Mirae Asset Global Etfs Holdings Ltd. Vera Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 30,905 shares of VERA stock, worth $949,710. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,905
Previous 28,695
7.7%
Holding current value
$949,710
Previous $1.21 Million
38.83%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
195Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$175 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$146 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$103 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$91 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$89.7 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $831M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...